je.st
news
Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...
2013-01-25 02:36:38| Biotech - Topix.net
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials evaluating a single tablet regimen containing tenofovir alafenamide for the treatment of HIV-1 infection in treatment-nai 1 2ve adults.
Tags: program
phase
clinical
initiates
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||